Cargando…
A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota
BACKGROUND: Successful chemoprevention or chemotherapy is achieved through targeted delivery of prophylactic agents during initial phases of carcinogenesis or therapeutic agents to malignant tumors. Bacteria can be used as anticancer agents, but efforts to utilize attenuated pathogenic bacteria suff...
Autores principales: | Chung, Yusook, Ryu, Yongku, An, Byung Chull, Yoon, Yeo-Sang, Choi, Oksik, Kim, Tai Yeub, Yoon, Jaekyung, Ahn, Jun Young, Park, Ho Jin, Kwon, Soon-Kyeong, Kim, Jihyun F., Chung, Myung Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157686/ https://www.ncbi.nlm.nih.gov/pubmed/34039418 http://dx.doi.org/10.1186/s40168-021-01071-4 |
Ejemplares similares
-
Colorectal Cancer Therapy Using a Pediococcus pentosaceus SL4 Drug Delivery System Secreting Lactic Acid Bacteria-Derived Protein p8
por: An, Byung Chull, et al.
Publicado: (2019) -
Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug
por: An, Byung Chull, et al.
Publicado: (2021) -
Anti-Colorectal Cancer Effects of Probiotic-Derived p8 Protein
por: An, Byung Chull, et al.
Publicado: (2019) -
Anti-Cancer Roles of Probiotic-Derived P8 Protein in Colorectal Cancer Cell Line DLD-1
por: An, Byung Chull, et al.
Publicado: (2023) -
Gut microbiota of the young ameliorates physical fitness of the aged in mice
por: Kim, Kwang H., et al.
Publicado: (2022)